Peng Xiao | Macrophage Biology | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Peng Xiao | Macrophage Biology | Best Researcher Award

Assoc Prof Dr. Peng Xiao, Zhejiang University, China

Dr. Peng Xiao, Assoc. Prof., is a distinguished immunologist specializing in Macrophage Biology. Holding an MD from Zhejiang University, he completed postdoctoral research at Harvard University before joining Zhejiang University as Assistant Professor, later promoted to Associate Professor. Dr. Xiao is a member of prestigious organizations including The American Association of Immunologists, Society for Mucosal Immunology, and Chinese Society for Immunology. He serves on the Editorial Board of the Journal of Leukocyte Biology. Passionate about unraveling mysteries of the immune system ๐Ÿฆ , Dr. Xiao’s research significantly contributes to understanding macrophage function and immunological processes.

Publication Profile:

Scopus

Orcid

Education:

Dr. Peng Xiao’s academic journey reflects a commitment to advancing knowledge in immunology. Beginning with his MD from Zhejiang University’s Institute of Immunology from 2011 to 2015 ๐ŸŽ“, he laid a solid foundation in medical science. Eager to delve deeper into research, he pursued a postdoctoral position at Harvard University’s Medicine School from 2019 to 2021 ๐Ÿฅ. During this time, he honed his expertise in macrophage biology, a field he’s passionate about.Returning to Zhejiang University in 2015, Dr. Xiao transitioned to the role of Assistant Professor, where he actively contributed to both teaching and research. Recognized for his exceptional dedication and contributions to the field, he was promoted to Associate Professor in 2019, reaffirming his position as a respected figure in academia ๐Ÿ“š.

Employment:

Dr. Peng Xiao’s professional journey spans across two renowned institutions, showcasing his dedication to advancing research in immunology. At Zhejiang University in Hangzhou, China ๐Ÿซ, Dr. Xiao has been deeply engaged in academia, contributing significantly as an Associate Professor. His tenure at this esteemed university underscores his commitment to education and research, where he actively participates in shaping the next generation of scholars and delving into the complexities of immunological science.In parallel, Dr. Xiao’s pursuit of excellence led him to Harvard Medical School in Boston, Massachusetts ๐Ÿ‡บ๐Ÿ‡ธ, where he undertook a prestigious postdoctoral position. Immersed in the vibrant academic environment of one of the world’s leading medical institutions, Dr. Xiao furthered his expertise in immunology, particularly in the field of macrophage biology. His time at Harvard Medical School not only enriched his knowledge but also facilitated collaborations and networking opportunities with leading experts in the field.Through his employment at both Zhejiang University and Harvard Medical School, Dr. Xiao demonstrates his unwavering dedication to advancing scientific knowledge and making meaningful contributions to the field of immunology. His experiences at these distinguished institutions have undoubtedly shaped his trajectory as a respected researcher and educator.

Research Focus:

Dr. Peng Xiao’s research focuses on immunological mechanisms and their implications in various diseases, particularly emphasizing macrophage biology. His work spans understanding the role of macrophages in gut homeostasis, melanoma progression, and pulmonary fibrosis, among other conditions. Through his investigations, Dr. Xiao has elucidated pathways involving cytokines like TNF-ฮฑ and IL-10, shedding light on potential therapeutic targets for inflammatory disorders and cancer. With a keen interest in unraveling the complexities of the immune system ๐Ÿงฌ, his contributions pave the way for novel interventions and treatments to alleviate disease burden and improve patient outcomes.

Publication Top Notes:

  1. Mannose metabolism normalizes gut homeostasis by blocking the TNF-ฮฑ-mediated proinflammatory circuit – Published in 2022 ๐Ÿ“š
  2. PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression – Published in 2022 ๐Ÿฉบ
  3. Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine – Published in 2022 ๐Ÿฆ 
  4. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-ฮฒ Production – Published in 2022 ๐Ÿซ
  5. Induction of co-inhibitory molecule CTLA-4 by human papillomavirus E7 protein through downregulation of histone methyltransferase JHDM1B expression – Published in 2019 ๐Ÿฆ 
  6. Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10 – Published in 2019 ๐Ÿงซ
  7. USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance – Published in 2019 ๐Ÿ”ฌ
  8. Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-ฮณ production in tumor microenvironment – Published in 2018 ๐Ÿฆ 
  9. Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation – Published in 2017 ๐Ÿงฌ
  10. E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses – Published in 2017 ๐Ÿฆ